158 related articles for article (PubMed ID: 10682429)
1. [The expression of glutathione S-transferase pi in human ovarian cancer as an indicator of resistance to chemotherapy].
Li L; Yao D; Chen X
Zhonghua Fu Chan Ke Za Zhi; 1998 Feb; 33(2):95-7. PubMed ID: 10682429
[TBL] [Abstract][Full Text] [Related]
2. [Expression of glutathione S-transferase-pi in operative specimens as marker of chemoresistance in patients with ovarian cancer].
Huang J; Gu M; Chen C
Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):458-61. PubMed ID: 9639737
[TBL] [Abstract][Full Text] [Related]
3. Glutathione S-transferase-pi expression and glutathione concentration in ovarian carcinoma before and after chemotherapy.
Cheng X; Kigawa J; Minagawa Y; Kanamori Y; Itamochi H; Okada M; Terakawa N
Cancer; 1997 Feb; 79(3):521-7. PubMed ID: 9028363
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of glutathione S-transferase-Pi can predict chemotherapy response in patients with nonsmall cell lung carcinoma.
Bai F; Nakanishi Y; Kawasaki M; Takayama K; Yatsunami J; Pei XH; Tsuruta N; Wakamatsu K; Hara N
Cancer; 1996 Aug; 78(3):416-21. PubMed ID: 8697385
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of glutathione transferase-pi in untreated primary non-small-cell lung cancer.
Arai T; Yasuda Y; Takaya T; Hayakawa K; Toshima S; Shibuya C; Kashiki Y; Yoshimi N; Shibayama M
Cancer Detect Prev; 2000; 24(3):252-7. PubMed ID: 10975287
[TBL] [Abstract][Full Text] [Related]
6. Glutathione-S transferase-pi expression in non small cell lung cancer in the assessment of response to chemotherapy.
Unsal M; Akpolat I; Kandemir B
Saudi Med J; 2003 May; 24(5):493-8. PubMed ID: 12847624
[TBL] [Abstract][Full Text] [Related]
7. The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocol.
Silvestrini R; Daidone MG; Veneroni S; Benini E; Scarfone G; Zanaboni F; Villa A; Presti M; Danese S; Bolis G
Cancer; 1998 Jan; 82(1):159-67. PubMed ID: 9428493
[TBL] [Abstract][Full Text] [Related]
8. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
9. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
[TBL] [Abstract][Full Text] [Related]
10. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors.
Cullen KJ; Newkirk KA; Schumaker LM; Aldosari N; Rone JD; Haddad BR
Cancer Res; 2003 Dec; 63(23):8097-102. PubMed ID: 14678959
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of dihydrodiol dehydrogenase is associated with cisplatin-based chemotherapy resistance in ovarian cancer patients.
Chen YJ; Yuan CC; Chow KC; Wang PH; Lai CR; Yen MS; Wang LS
Gynecol Oncol; 2005 Apr; 97(1):110-7. PubMed ID: 15790446
[TBL] [Abstract][Full Text] [Related]
12. Tumor response to neoadjuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-pi in the tumor cells of cervical carcinoma.
Konishi I; Nanbu K; Mandai M; Tsuruta Y; Kataoka N; Nagata Y; Mori T
Gynecol Oncol; 1998 Sep; 70(3):365-71. PubMed ID: 9790789
[TBL] [Abstract][Full Text] [Related]
13. [Expression of glutathione S-transferase pi and numerical aberration of chromosome 11 in human ovarian cancer as a prognostic indicator].
Yokoyama Y; Fukushi Y; Kunugi T; Maruyama H; Sato S; Saito Y
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Feb; 48(2):118-24. PubMed ID: 8718547
[TBL] [Abstract][Full Text] [Related]
14. Significance of the O6-methylguanine-DNA methyltransferase and glutathione S-transferase activity in the sera of patients with malignant and benign ovarian tumors.
Akçay T; Dinçer Y; Alademir Z; Aydinli K; Arvas M; Demirkiran F; Kösebay D
Eur J Obstet Gynecol Reprod Biol; 2005 Mar; 119(1):108-13. PubMed ID: 15734094
[TBL] [Abstract][Full Text] [Related]
15. Estimation of glutathione S-transferase and its Pi isoenzyme in tumor tissues and sera of patients with ovarian cancer.
Ghalia AA; Rabboh NA; el Shalakani A; Seada L; Khalifa A
Anticancer Res; 2000; 20(2B):1229-35. PubMed ID: 10810426
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer.
Huang J; Tan PH; Thiyagarajan J; Bay BH
Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061
[TBL] [Abstract][Full Text] [Related]
17. [An immunohistological study on expression of glutathione S-transferase pi (form) in human ovarian carcinoma].
Satoh T; Nishida M; Miyazaki Y; Sugita M; Arisawa Y; Oki A; Nishide K; Kono K; Tsunoda H; Kubo T
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Sep; 47(9):931-8. PubMed ID: 7594904
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of mutant p53 protein, P-glycoprotein and glutathione S-transferase-pi in patients with unresectable non-small cell lung cancer.
Miyatake K; Gemba K; Ueoka H; Nishii K; Kiura K; Tabata M; Shibayama T; Takigawa N; Kawaraya M; Tanimoto M
Anticancer Res; 2003; 23(3C):2829-36. PubMed ID: 12926120
[TBL] [Abstract][Full Text] [Related]
19. Glutathione, glutathione S-transferase alpha and pi, and aldehyde dehydrogenase content in relationship to drug resistance in ovarian cancer.
Tanner B; Hengstler JG; Dietrich B; Henrich M; Steinberg P; Weikel W; Meinert R; Kaina B; Oesch F; Knapstein PG
Gynecol Oncol; 1997 Apr; 65(1):54-62. PubMed ID: 9103391
[TBL] [Abstract][Full Text] [Related]
20. [Expression and significance of GST-Pi and HIF-1alpha in bladder carcinoma].
Deng JH; Bai JL; Ma PC; Zhang SS; Wan JH
Ai Zheng; 2006 Feb; 25(2):190-3. PubMed ID: 16480584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
